RTOG Symposium COX-2 Inhibitors and Cancer Therapeutics

被引：0

|

作者：

Dicker, AP

机构：

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2003年 / 26卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：S45 / S45

页数：1

相关论文

共 50 条

[41] Novel COX-2 inhibitors
Lloyd, AW
DRUG DISCOVERY TODAY, 1998, 3 (08) : 386 - 386
[42] COX-2 inhibitors and the kidney
Appel, GB
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2001, 19 (06) : S37 - S40
[43] COX-2 inhibitors - Preface
Brooks, PM
CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (17) : U2 - U4
[44] COX-2 inhibitors and ligaments
Mitka, M
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (24): : 3071 - 3071
[45] COX-2 inhibitors and the kidney
Perazella, MA
HOSPITAL PRACTICE, 2001, 36 (03): : 43 - +
[46] COX-2 inhibitors and hypertension
Weder, Alan B.
Zhang, J.
Ding, E. L.
Song, Y.
CURRENT HYPERTENSION REPORTS, 2007, 9 (01) : 3 - 4
[47] COX-2 inhibition in cancer therapeutics: a field of controversy or a magic bullet?
Karamouzis, MV
Papavassiliou, AG
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (04) : 359 - 372
[48] COX-1 and COX-2 inhibitors
Hawkey, CJ
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2001, 15 (05) : 801 - 820
[49] COX-2 independent induction of apoptosis by two synthetic COX-2 inhibitors in breast cancer cell line
Salimi, M.
Norouzi, S.
Norouzi, M.
Amini, M.
Amanzadeh, A.
EUROPEAN JOURNAL OF CANCER, 2014, 50 : S40 - S40
[50] Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
Debabrata Mukherjee
Eric J Topol
Arthritis Res Ther, 5

← 1 2 3 4 5 →